source
- Biomarker testing guides endometrial cancer treatment and highlights gaps in second-line options after immunotherapyThe discussion highlighted that performing biomarker testing at diagnosis is now standard for endometrial cancer, helping decide between targeted therapies and immunotherapy. The experts described…
- Alpha-emitting radiopharmaceuticals gain attention in metastatic castration-resistant prostate cancerDr. Johann De Bono and Dr. Pedro Barata reviewed the current landscape of alpha-emitting radiopharmaceuticals for patients with metastatic castration-resistant prostate cancer (mCRPC). They highli…